<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39223311</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1471-0064</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Sep</Month><Day>02</Day></PubDate></JournalIssue><Title>Nature reviews. Genetics</Title><ISOAbbreviation>Nat Rev Genet</ISOAbbreviation></Journal><ArticleTitle>Progress in toxicogenomics to protect human health.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41576-024-00767-1</ELocationID><Abstract><AbstractText>Toxicogenomics measures molecular features, such as transcripts, proteins, metabolites and epigenomic modifications, to understand and predict the toxicological effects of environmental and pharmaceutical exposures. Transcriptomics has become an integral tool in contemporary toxicology research owing to innovations in gene expression profiling that can provide mechanistic and quantitative information at scale. These data can be used to predict toxicological hazards through the use of transcriptomic biomarkers, network inference analyses, pattern-matching approaches and artificial intelligence. Furthermore, emerging approaches, such as high-throughput dose-response modelling, can leverage toxicogenomic data for human health protection even in the absence of predicting specific hazards. Finally, single-cell transcriptomics and multi-omics provide detailed insights into toxicological mechanisms. Here, we review the progress since the inception of toxicogenomics in applying transcriptomics towards toxicology testing and highlight advances that are transforming risk assessment.</AbstractText><CopyrightInformation>© 2024. Springer Nature Limited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Meier</LastName><ForeName>Matthew J</ForeName><Initials>MJ</Initials><Identifier Source="ORCID">0000-0001-8199-8754</Identifier><AffiliationInfo><Affiliation>Environmental Health Science and Research Bureau, Health Canada, Ottawa, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harrill</LastName><ForeName>Joshua</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-4317-6391</Identifier><AffiliationInfo><Affiliation>Center for Computational Toxicology and Exposure, Office of Research and Development, U.S. Environmental Protection Agency, Research Triangle Park, Durham, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johnson</LastName><ForeName>Kamin</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-4550-5566</Identifier><AffiliationInfo><Affiliation>Predictive Safety Center, Corteva Agriscience, Indianapolis, IN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thomas</LastName><ForeName>Russell S</ForeName><Initials>RS</Initials><AffiliationInfo><Affiliation>Center for Computational Toxicology and Exposure, Office of Research and Development, U.S. Environmental Protection Agency, Research Triangle Park, Durham, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tong</LastName><ForeName>Weida</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0003-3488-6148</Identifier><AffiliationInfo><Affiliation>Division of Bioinformatics and Biostatistics, National Center for Toxicological Research, United States Food and Drug Administration, Jefferson, AR, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Curriculum in Toxicology &amp; Environmental Medicine, School of Medicine, University of North Carolina, Chapel Hill, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rager</LastName><ForeName>Julia E</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Curriculum in Toxicology &amp; Environmental Medicine, School of Medicine, University of North Carolina, Chapel Hill, NC, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Center for Environmental Medicine, Asthma and Lung Biology, School of Medicine, The University of North Carolina, Chapel Hill, NC, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Environmental Sciences and Engineering, Gillings School of Global Public Health, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Institute for Environmental Health Solutions, Gillings School of Global Public Health, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yauk</LastName><ForeName>Carole L</ForeName><Initials>CL</Initials><Identifier Source="ORCID">0000-0002-6725-3454</Identifier><AffiliationInfo><Affiliation>Department of Biology, University of Ottawa, Ottawa, Ontario, Canada. carole.yauk@uottawa.ca.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Rev Genet</MedlineTA><NlmUniqueID>100962779</NlmUniqueID><ISSNLinking>1471-0056</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>3</Day><Hour>1</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>3</Day><Hour>1</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>2</Day><Hour>23</Hour><Minute>28</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39223311</ArticleId><ArticleId IdType="doi">10.1038/s41576-024-00767-1</ArticleId><ArticleId IdType="pii">10.1038/s41576-024-00767-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nuwaysir, E. F., Bittner, M., Trent, J., Barrett, J. C. &amp; Afshari, C. A. Microarrays and toxicology: the advent of toxicogenomics. Mol. Carcinog. 24, 153 (1999). This was the original paper that introduced the concept of toxicogenomics and coined the term.</Citation><ArticleIdList><ArticleId IdType="pubmed">10204799</ArticleId><ArticleId IdType="doi">10.1002/(SICI)1098-2744(199903)24:3&lt;153::AID-MC1&gt;3.0.CO;2-P</ArticleId></ArticleIdList></Reference><Reference><Citation>Waters, M. D. &amp; Fostel, J. M. Toxicogenomics and systems toxicology: aims and prospects. Nat. Rev. 5, 936–948 (2004).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrg1493</ArticleId></ArticleIdList></Reference><Reference><Citation>Krewski, D. et al. Toxicity testing in the 21st century: progress in the past decade and future perspectives. Arch. Toxicol. 94, 1–58 (2020). This paper summarizes key progress in moving regulatory toxicological testing away from vertebrate animal testing toward the use of in vitro and in silico models and mechanistic information.</Citation><ArticleIdList><ArticleId IdType="pubmed">31848664</ArticleId><ArticleId IdType="doi">10.1007/s00204-019-02613-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Krewski, D. et al. Toxicity testing in the 21st century: a vision and a strategy. J. Toxicol. Environ. Health B Crit. Rev. 13, 51–138 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20574894</ArticleId><ArticleId IdType="pmc">4410863</ArticleId><ArticleId IdType="doi">10.1080/10937404.2010.483176</ArticleId></ArticleIdList></Reference><Reference><Citation>Souza, T. M., Kleinjans, J. C. S. &amp; Jennen, D. G. J. In Big Data in Predictive Toxicology (eds Neagu, D. &amp; Richarz, A.-N.) Ch. 7 https://doi.org/10.1039/9781782623656-00214 (Royal Society of Chemistry, 2019).</Citation></Reference><Reference><Citation>Afshari, C. A., Hamadeh, H. K. &amp; Bushel, P. R. The evolution of bioinformatics in toxicology: advancing toxicogenomics. Toxicol. Sci. 120, S225–S237 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">21177775</ArticleId><ArticleId IdType="doi">10.1093/toxsci/kfq373</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian, A. et al. A next generation connectivity map: L1000 platform and the first 1,000,000 profiles. Cell 171, 1437–1452.e17 (2017). This highly expanded Connectivity Map is a powerful tool to discover toxicological mechanism of action and predict chemical hazards.</Citation><ArticleIdList><ArticleId IdType="pubmed">29195078</ArticleId><ArticleId IdType="pmc">5990023</ArticleId><ArticleId IdType="doi">10.1016/j.cell.2017.10.049</ArticleId></ArticleIdList></Reference><Reference><Citation>D’Agostino, N., Li, W. &amp; Wang, D. High-throughput transcriptomics. Sci. Rep. 12, 20313 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">36446824</ArticleId><ArticleId IdType="pmc">9708670</ArticleId><ArticleId IdType="doi">10.1038/s41598-022-23985-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Deshpande, D. et al. RNA-seq data science: from raw data to effective interpretation. Front. Genet. 14, 997383 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36999049</ArticleId><ArticleId IdType="pmc">10043755</ArticleId><ArticleId IdType="doi">10.3389/fgene.2023.997383</ArticleId></ArticleIdList></Reference><Reference><Citation>Mav, D. et al. A hybrid gene selection approach to create the S1500+ targeted gene sets for use in high-throughput transcriptomics. PLoS One 13, e0191105 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29462216</ArticleId><ArticleId IdType="pmc">5819766</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0191105</ArticleId></ArticleIdList></Reference><Reference><Citation>Balik-Meisner, M. R. et al. Development of a zebrafish S1500+ sentinel gene set for high-throughput transcriptomics. Zebrafish 16, 331–347 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31188086</ArticleId><ArticleId IdType="pmc">6685209</ArticleId><ArticleId IdType="doi">10.1089/zeb.2018.1720</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, H., Qiu, J. &amp; Fu, X.-D. RASL-seq for massively parallel and quantitative analysis of gene expression. Curr. Protoc. Mol. Biol. 98, 4.13.1–4.13.9 (2012).</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/0471142727.mb0413s98</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye, C. et al. DRUG-seq for miniaturized high-throughput transcriptome profiling in drug discovery. Nat. Commun. 9, 4307 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">30333485</ArticleId><ArticleId IdType="pmc">6192987</ArticleId><ArticleId IdType="doi">10.1038/s41467-018-06500-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon, J. M., Paranjape, S. R., Wolter, J. M., Salazar, G. &amp; Zylka, M. J. High-throughput screening and classification of chemicals and their effects on neuronal gene expression using RASL-seq. Sci. Rep. 9, 4529 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30872602</ArticleId><ArticleId IdType="pmc">6418307</ArticleId><ArticleId IdType="doi">10.1038/s41598-019-39016-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowan-Carroll, A. et al. High-throughput transcriptomic analysis of human primary hepatocyte spheroids exposed to per- and polyfluoroalkyl substances as a platform for relative potency characterization. Toxicol. Sci. 181, 199–214 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33772556</ArticleId><ArticleId IdType="doi">10.1093/toxsci/kfab039</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramaiahgari, S. C. et al. The power of resolution: contextualized understanding of biological responses to liver injury chemicals using high-throughput transcriptomics and benchmark concentration modeling. Toxicol. Sci. 169, 553–566 (2019). The power of concentration-response modelling of high-throughput transcriptomic data in this paper demonstrates its potential to effectively predict human liver injury from chemical exposures, showcasing the predictive capacity of toxicogenomics.</Citation><ArticleIdList><ArticleId IdType="pubmed">30850835</ArticleId><ArticleId IdType="pmc">6542332</ArticleId><ArticleId IdType="doi">10.1093/toxsci/kfz065</ArticleId></ArticleIdList></Reference><Reference><Citation>Chin, K.-V. &amp; Kong, A.-N. T. Application of DNA microarrays in pharmacogenomics and toxicogenomics. Pharm. Res. 19, 1773–1778 (2002).</Citation><ArticleIdList><ArticleId IdType="pubmed">12523654</ArticleId><ArticleId IdType="doi">10.1023/A:1021425004264</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, Z., Gerstein, M. &amp; Snyder, M. RNA-Seq: a revolutionary tool for transcriptomics. Nat. Rev. Genet. 10, 57–63 (2009).</Citation><ArticleIdList><ArticleId IdType="pubmed">19015660</ArticleId><ArticleId IdType="pmc">2949280</ArticleId><ArticleId IdType="doi">10.1038/nrg2484</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeakley, J. M. et al. A trichostatin A expression signature identified by TempO-Seq targeted whole transcriptome profiling. PLoS One 12, e0178302 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28542535</ArticleId><ArticleId IdType="pmc">5444820</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0178302</ArticleId></ArticleIdList></Reference><Reference><Citation>Soufan, O. et al. T1000: a reduced gene set prioritized for toxicogenomic studies. PeerJ 7, e7975 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31681519</ArticleId><ArticleId IdType="pmc">6824333</ArticleId><ArticleId IdType="doi">10.7717/peerj.7975</ArticleId></ArticleIdList></Reference><Reference><Citation>Haider, S. et al. A qualitative modeling approach for whole genome prediction using high-throughput toxicogenomics data and pathway-based validation. Front. Pharmacol. 9, 1072 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">30333746</ArticleId><ArticleId IdType="pmc">6176017</ArticleId><ArticleId IdType="doi">10.3389/fphar.2018.01072</ArticleId></ArticleIdList></Reference><Reference><Citation>Love, M. I., Huber, W. &amp; Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550–558 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">25516281</ArticleId><ArticleId IdType="pmc">4302049</ArticleId><ArticleId IdType="doi">10.1186/s13059-014-0550-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson, M. D., McCarthy, D. J. &amp; Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139–140 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">19910308</ArticleId><ArticleId IdType="doi">10.1093/bioinformatics/btp616</ArticleId></ArticleIdList></Reference><Reference><Citation>Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25605792</ArticleId><ArticleId IdType="pmc">4402510</ArticleId><ArticleId IdType="doi">10.1093/nar/gkv007</ArticleId></ArticleIdList></Reference><Reference><Citation>Verheijen, M. C. et al. R-ODAF: omics data analysis framework for regulatory application. Regul. Toxicol. Pharmacol. 131, 105143 (2022). R-ODAF provides a robust method designed to enhance the reproducibility and credibility of transcriptomics data in regulatory toxicology, thereby improving its acceptance by regulatory agencies for hazard assessment.</Citation><ArticleIdList><ArticleId IdType="pubmed">35247516</ArticleId><ArticleId IdType="doi">10.1016/j.yrtph.2022.105143</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, P. et al. ExpressAnalyst: a unified platform for RNA-sequencing analysis in non-model species. Nat. Commun. 14, 2995 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37225696</ArticleId><ArticleId IdType="pmc">10209063</ArticleId><ArticleId IdType="doi">10.1038/s41467-023-38785-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545–15550 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">16199517</ArticleId><ArticleId IdType="pmc">1239896</ArticleId><ArticleId IdType="doi">10.1073/pnas.0506580102</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashburner, M. et al. Gene Ontology: tool for the unification of biology. Nat. Genet. 25, 25–29 (2000).</Citation><ArticleIdList><ArticleId IdType="pubmed">10802651</ArticleId><ArticleId IdType="pmc">3037419</ArticleId><ArticleId IdType="doi">10.1038/75556</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanehisa, M. &amp; Goto, S. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 28, 27–30 (2000).</Citation><ArticleIdList><ArticleId IdType="pubmed">10592173</ArticleId><ArticleId IdType="pmc">102409</ArticleId><ArticleId IdType="doi">10.1093/nar/28.1.27</ArticleId></ArticleIdList></Reference><Reference><Citation>Martens, M. et al. WikiPathways: connecting communities. Nucleic Acids Res. 49, D613–D621 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33211851</ArticleId><ArticleId IdType="doi">10.1093/nar/gkaa1024</ArticleId></ArticleIdList></Reference><Reference><Citation>Milacic, M. et al. The Reactome Pathway Knowledgebase 2024. Nucleic Acids Res. 52, D672–D678 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">37941124</ArticleId><ArticleId IdType="doi">10.1093/nar/gkad1025</ArticleId></ArticleIdList></Reference><Reference><Citation>Liberzon, A. et al. Molecular signatures database (MSigDB) 3.0. Bioinformatics 27, 1739–1740 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">21546393</ArticleId><ArticleId IdType="pmc">3106198</ArticleId><ArticleId IdType="doi">10.1093/bioinformatics/btr260</ArticleId></ArticleIdList></Reference><Reference><Citation>Krämer, A., Green, J., Pollard, J. Jr &amp; Tugendreich, S. Causal analysis approaches in ingenuity pathway analysis. Bioinformatics 30, 523–530 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24336805</ArticleId><ArticleId IdType="doi">10.1093/bioinformatics/btt703</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamburov, A. &amp; Herwig, R. ConsensusPathDB 2022: molecular interactions update as a resource for network biology. Nucleic Acids Res. 50, D587–D595 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">8728246</ArticleId><ArticleId IdType="doi">10.1093/nar/gkab1128</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrill, J. A. et al. Progress towards an OECD reporting framework for transcriptomics and metabolomics in regulatory toxicology. Regul. Toxicol. Pharmacol. 125, 105020 (2021). Initiated by the OECD, this paper describes the first formal reporting framework for regulatory submission of omics data, aimed at enhancing transparency, standardization and regulatory acceptance of omics methodologies in toxicological research.</Citation><ArticleIdList><ArticleId IdType="pubmed">34333066</ArticleId><ArticleId IdType="pmc">8808338</ArticleId><ArticleId IdType="doi">10.1016/j.yrtph.2021.105020</ArticleId></ArticleIdList></Reference><Reference><Citation>Das, S., McClain, C. J. &amp; Rai, S. N. Fifteen years of gene set analysis for high-throughput genomic data: a review of statistical approaches and future challenges. Entropy 22, 427 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">33286201</ArticleId><ArticleId IdType="pmc">7516904</ArticleId><ArticleId IdType="doi">10.3390/e22040427</ArticleId></ArticleIdList></Reference><Reference><Citation>Sewer, A., Talikka, M., Martin, F., Hoeng, J. &amp; Peitsch, M. C. In Bioinformatics in the Era of Post Genomics and Big Data (ed. Abdurakhmonov, I. Y.) (InTech, 2018).</Citation></Reference><Reference><Citation>Alexander-Dann, B. et al. Developments in toxicogenomics: understanding and predicting compound-induced toxicity from gene expression data. Mol. Omics 14, 218–236 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29917034</ArticleId><ArticleId IdType="pmc">6080592</ArticleId><ArticleId IdType="doi">10.1039/C8MO00042E</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah, I. et al. Navigating transcriptomic connectivity mapping workflows to link chemicals with bioactivities. Chem. Res. Toxicol. 35, 1929–1949 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">36301716</ArticleId><ArticleId IdType="pmc">10483698</ArticleId><ArticleId IdType="doi">10.1021/acs.chemrestox.2c00245</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrill, J. A. et al. High-throughput transcriptomics platform for screening environmental chemicals. Toxicol. Sci. 181, 68–89 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33538836</ArticleId><ArticleId IdType="doi">10.1093/toxsci/kfab009</ArticleId></ArticleIdList></Reference><Reference><Citation>Caiment, F., Tsamou, M., Jennen, D. &amp; Kleinjans, J. Assessing compound carcinogenicity in vitro using connectivity mapping. Carcinogenesis 35, 201–207 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">23940306</ArticleId><ArticleId IdType="doi">10.1093/carcin/bgt278</ArticleId></ArticleIdList></Reference><Reference><Citation>De Abrew, K. N. et al. Use of connectivity mapping to support read across: a deeper dive using data from 186 chemicals, 19 cell lines and 2 case studies. Toxicology 423, 84–94 (2019). Expanded application of the CMap concept for predictive toxicology is described, demonstrating its utility in read-across by identifying biologically and functionally relevant chemical analogues for target structures and emphasizing the critical influence of factors, such as chemical promiscuity, concentration, cell line and time point, on outcomes.</Citation><ArticleIdList><ArticleId IdType="pubmed">31125584</ArticleId><ArticleId IdType="doi">10.1016/j.tox.2019.05.008</ArticleId></ArticleIdList></Reference><Reference><Citation>Su, Z. et al. An investigation of biomarkers derived from legacy microarray data for their utility in the RNA-seq era. Genome Biol. 15, 523 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">25633159</ArticleId><ArticleId IdType="doi">10.1186/s13059-014-0523-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan, X. et al. Consistency of predictive signature genes and classifiers generated using different microarray platforms. Pharmacogenomics J. 10, 247–257 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20676064</ArticleId><ArticleId IdType="pmc">2920073</ArticleId><ArticleId IdType="doi">10.1038/tpj.2010.34</ArticleId></ArticleIdList></Reference><Reference><Citation>Thienpont, A. et al. Unlocking the power of transcriptomic biomarkers in qualitative and quantitative genotoxicity assessment of chemicals. Chem. Res. Toxicol. 37, 465–475 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">38408751</ArticleId><ArticleId IdType="pmc">10952014</ArticleId><ArticleId IdType="doi">10.1021/acs.chemrestox.3c00318</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, Z., Walker, G. W., Muir, D. C. G. &amp; Nagatani-Yoshida, K. Toward a global understanding of chemical pollution: a first comprehensive analysis of national and regional chemical inventories. Environ. Sci. Technol. 54, 2575–2584 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">31968937</ArticleId><ArticleId IdType="doi">10.1021/acs.est.9b06379</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamb, J. et al. The connectivity map: using gene-expression signatures to connect small molecules, genes, and disease. Science 313, 1929–1935 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">17008526</ArticleId><ArticleId IdType="doi">10.1126/science.1132939</ArticleId></ArticleIdList></Reference><Reference><Citation>Sutherland, J. J. et al. Toxicogenomic module associations with pathogenesis: a network-based approach to understanding drug toxicity. Pharmacogenomics J. 18, 377–390 (2018). Co-expression network analysis of rat liver gene expression data was applied for safety assessment, illustrating how this approach can enhance the prediction of toxicity phenotypes, complement traditional assessments, identify novel mechanisms and biomarkers of hepatotoxicity, and be used to bridge findings from rat models to humans.</Citation><ArticleIdList><ArticleId IdType="pubmed">28440344</ArticleId><ArticleId IdType="doi">10.1038/tpj.2017.17</ArticleId></ArticleIdList></Reference><Reference><Citation>De Abrew, K. N. et al. Grouping 34 chemicals based on mode of action using connectivity mapping. Toxicol. Sci. 151, 447–461 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27026708</ArticleId><ArticleId IdType="doi">10.1093/toxsci/kfw058</ArticleId></ArticleIdList></Reference><Reference><Citation>Igarashi, Y. et al. Open TG-GATEs: a large-scale toxicogenomics database. Nucleic Acids Res. 43, 921 (2015).</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gku955</ArticleId></ArticleIdList></Reference><Reference><Citation>House, J. S. et al. Grouping of UVCB substances with dose-response transcriptomics data from human cell-based assays. ALTEX 39, 388–404 (2022). A demonstration of how transcriptomics can be used for grouping unknown or variable composition substances, revealing distinct transcriptional responses by manufacturing class and demonstrating value in supporting the regulatory grouping and characterization of complex chemical substances.</Citation><ArticleIdList><ArticleId IdType="pubmed">35288757</ArticleId><ArticleId IdType="pmc">9344966</ArticleId></ArticleIdList></Reference><Reference><Citation>Koval, L. E. et al. Wildfire variable toxicity: identifying biomass smoke exposure groupings through transcriptomic similarity scoring. Environ. Sci. Technol. 56, 17131–17142 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">36399130</ArticleId><ArticleId IdType="pmc">10777820</ArticleId><ArticleId IdType="doi">10.1021/acs.est.2c06043</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, Z., Huang, R., Roberts, R. &amp; Tong, W. Toxicogenomics: a 2020 vision. Trends Pharmacol. Sci. 40, 92–103 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30594306</ArticleId><ArticleId IdType="doi">10.1016/j.tips.2018.12.001</ArticleId></ArticleIdList></Reference><Reference><Citation>Forreryd, A. et al. The GARD<sup>TM</sup>skin assay: investigation of the applicability domain for metals. ALTEX 40, 425–438 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36343115</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansson, H. et al. Validation of the GARDskin assay for assessment of chemical skin sensitizers: ring trial results of predictive performance and reproducibility. Toxicol. Sci. 170, 374–381 (2019). Analysis of the GARDskin assay shows its high predictive accuracy and reproducibility across different laboratories, which supports its potential for regulatory validation and broader adoption in chemical safety assessment.</Citation><ArticleIdList><ArticleId IdType="pubmed">31099396</ArticleId><ArticleId IdType="pmc">6657565</ArticleId><ArticleId IdType="doi">10.1093/toxsci/kfz108</ArticleId></ArticleIdList></Reference><Reference><Citation>Gradin, R., Forreryd, A., Mattson, U., Jerre, A. &amp; Johansson, H. Quantitative assessment of sensitizing potency using a dose–response adaptation of GARDskin. Sci. Rep. 11, 18904 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34556744</ArticleId><ArticleId IdType="pmc">8460622</ArticleId><ArticleId IdType="doi">10.1038/s41598-021-98247-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Organisation for Economic Co-operation and Development. Test No. 442E: In Vitro Skin Sensitisation: In Vitro Skin Sensitisation Assays Addressing the Key Event on Activation of Dendritic Cells on the Adverse Outcome Pathway for Skin Sensitisation (OECD, 2023).</Citation></Reference><Reference><Citation>Lejal, V., Cerisier, N., Rouquié, D. &amp; Taboureau, O. Assessment of drug-induced liver injury through cell morphology and gene expression analysis. Chem. Res. Toxicol. 36, 1456–1470 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37652439</ArticleId><ArticleId IdType="pmc">10523580</ArticleId><ArticleId IdType="doi">10.1021/acs.chemrestox.2c00381</ArticleId></ArticleIdList></Reference><Reference><Citation>Govaere, O. et al. Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis. Sci. Transl. Med. 12, eaba4448 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">33268509</ArticleId><ArticleId IdType="doi">10.1126/scitranslmed.aba4448</ArticleId></ArticleIdList></Reference><Reference><Citation>Kohonen, P. et al. A transcriptomics data-driven gene space accurately predicts liver cytopathology and drug-induced liver injury. Nat. Commun. 8, 15932 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28671182</ArticleId><ArticleId IdType="pmc">5500850</ArticleId><ArticleId IdType="doi">10.1038/ncomms15932</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, H.-H. et al. Development and validation of a high-throughput transcriptomic biomarker to address 21st century genetic toxicology needs. Proc. Natl Acad. Sci. USA 114, E10881–E10889 (2017). This paper describes the development and validation of the TGx-DDI transcriptomic biomarker that is used to enhance the interpretation of in vitro genotoxicity tests.</Citation><ArticleIdList><ArticleId IdType="pubmed">29203651</ArticleId><ArticleId IdType="pmc">5754797</ArticleId><ArticleId IdType="doi">10.1073/pnas.1714109114</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, H.-H. et al. TGx-DDI, a transcriptomic biomarker for genotoxicity hazard assessment of pharmaceuticals and environmental chemicals. Front. Big Data 2, 36 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">33693359</ArticleId><ArticleId IdType="pmc">7931968</ArticleId><ArticleId IdType="doi">10.3389/fdata.2019.00036</ArticleId></ArticleIdList></Reference><Reference><Citation>Thienpont, A. et al. Novel prediction models for genotoxicity based on biomarker genes in human HepaRG<sup>TM</sup> cells. ALTEX 40, 271–286 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36343114</ArticleId></ArticleIdList></Reference><Reference><Citation>Ates, G. et al. A novel genotoxin-specific qPCR array based on the metabolically competent human HepaRG<sup>TM</sup> cell line as a rapid and reliable tool for improved in vitro hazard assessment. Arch. Toxicol. 92, 1593–1608 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29411056</ArticleId><ArticleId IdType="doi">10.1007/s00204-018-2172-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Rooney, J., Hill, T., Qin, C., Sistare, F. D. &amp; Corton, J. C. Adverse outcome pathway-driven identification of rat liver tumorigens in short-term assays. Toxicol. Appl. Pharmacol. 356, 99–113 (2018). This paper describes the identification of transcriptomic biomarkers from short-term rat tests that predict tumorigenic potential of chemicals in 2-year bioassays with high accuracy, thereby offering a promising method for early identification of liver carcinogens in rodents.</Citation><ArticleIdList><ArticleId IdType="pubmed">30048669</ArticleId><ArticleId IdType="doi">10.1016/j.taap.2018.07.023</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis, R. W., Hill, T. &amp; Corton, J. C. A set of six gene expression biomarkers and their thresholds identify rat liver tumorigens in short-term assays. Toxicology 443, 152547 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32755643</ArticleId><ArticleId IdType="doi">10.1016/j.tox.2020.152547</ArticleId></ArticleIdList></Reference><Reference><Citation>Corton, J. C., Hill, T., Sutherland, J. J., Stevens, J. L. &amp; Rooney, J. A set of six gene expression biomarkers identify rat liver tumorigens in short-term assays. Toxicol. Sci. 177, 11–26 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32603430</ArticleId><ArticleId IdType="doi">10.1093/toxsci/kfaa101</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, A. et al. The carcinogenome project: in vitro gene expression profiling of chemical perturbations to predict long-term carcinogenicity. Environ. Health Perspect. 127, 047002 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30964323</ArticleId><ArticleId IdType="pmc">6785232</ArticleId><ArticleId IdType="doi">10.1289/EHP3986</ArticleId></ArticleIdList></Reference><Reference><Citation>Oku, Y. et al. Analyses of transcriptomics cell signalling for pre-screening applications in the integrated approach for testing and assessment of non-genotoxic carcinogens. Int. J. Mol. Sci. 23, 12718 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">36361516</ArticleId><ArticleId IdType="pmc">9659232</ArticleId><ArticleId IdType="doi">10.3390/ijms232112718</ArticleId></ArticleIdList></Reference><Reference><Citation>Schaap, M. M. et al. A novel toxicogenomics-based approach to categorize (non-)genotoxic carcinogens. Arch. Toxicol. 89, 2413–2427 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25270620</ArticleId><ArticleId IdType="doi">10.1007/s00204-014-1368-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayobahan, S. U. et al. Comprehensive identification of gene expression fingerprints and biomarkers of sexual endocrine disruption in zebrafish embryo. Ecotoxicol. Environ. Saf. 250, 114514 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36608563</ArticleId><ArticleId IdType="doi">10.1016/j.ecoenv.2023.114514</ArticleId></ArticleIdList></Reference><Reference><Citation>Corton, J. C., Kleinstreuer, N. C. &amp; Judson, R. S. Identification of potential endocrine disrupting chemicals using gene expression biomarkers. Toxicol. Appl. Pharmacol. 380, 114683 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31325560</ArticleId><ArticleId IdType="doi">10.1016/j.taap.2019.114683</ArticleId></ArticleIdList></Reference><Reference><Citation>Fortin, A.-M. V. et al. Application of a new approach methodology (NAM)-based strategy for genotoxicity assessment of data-poor compounds. Front. Toxicol. 5, 1098432 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36756349</ArticleId><ArticleId IdType="pmc">9899896</ArticleId><ArticleId IdType="doi">10.3389/ftox.2023.1098432</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, X. et al. Toxicological mechanisms and potencies of organophosphate esters in KGN human ovarian granulosa cells as revealed by high-throughput transcriptomics. Toxicol. Sci. 197, 170–185 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37941476</ArticleId><ArticleId IdType="doi">10.1093/toxsci/kfad114</ArticleId></ArticleIdList></Reference><Reference><Citation>Langfelder, P. &amp; Horvath, S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics 9, 559 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">19114008</ArticleId><ArticleId IdType="pmc">2631488</ArticleId><ArticleId IdType="doi">10.1186/1471-2105-9-559</ArticleId></ArticleIdList></Reference><Reference><Citation>Vrijenhoek, N. G. et al. Application of high-throughput transcriptomics for mechanism-based biological read-across of short-chain carboxylic acid analogues of valproic acid. ALTEX 39, 207–220 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35040482</ArticleId></ArticleIdList></Reference><Reference><Citation>Callegaro, G. et al. The human hepatocyte TXG-MAPr: gene co-expression network modules to support mechanism-based risk assessment. Arch. Toxicol. 95, 3745–3775 (2021). The TXG-MAPr webtool uses WGCNA to enhance the interpretation of toxicogenomic data, providing a mechanism-based approach for assessing chemical toxicity across species and experimental platforms.</Citation><ArticleIdList><ArticleId IdType="pubmed">34626214</ArticleId><ArticleId IdType="pmc">8536636</ArticleId><ArticleId IdType="doi">10.1007/s00204-021-03141-w</ArticleId></ArticleIdList></Reference><Reference><Citation>Callegaro, G. et al. Identifying multiscale translational safety biomarkers using a network-based systems approach. iScience 26, 106094 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36895646</ArticleId><ArticleId IdType="pmc">9988559</ArticleId><ArticleId IdType="doi">10.1016/j.isci.2023.106094</ArticleId></ArticleIdList></Reference><Reference><Citation>Pognan, F. et al. The evolving role of investigative toxicology in the pharmaceutical industry. Nat. Rev. Drug Discov. 22, 317–335 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36781957</ArticleId><ArticleId IdType="pmc">9924869</ArticleId><ArticleId IdType="doi">10.1038/s41573-022-00633-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijaya, L. S. et al. A network-based transcriptomic landscape of HepG2 cells uncovering causal gene-cytotoxicity interactions underlying drug-induced liver injury. Toxicol. Sci. 198, 14–30 (2024). Using HepG2 cells, researchers applied WGCNA to identify gene networks linked to drug-induced liver injury, revealing key modulators that may improve our understanding of drug-induced liver injury mechanisms and potentially aid in drug development.</Citation><ArticleIdList><ArticleId IdType="pubmed">38015832</ArticleId><ArticleId IdType="doi">10.1093/toxsci/kfad121</ArticleId></ArticleIdList></Reference><Reference><Citation>Borzelleca, J. F. Paracelsus: herald of modern toxicology. Toxicol. Sci. 53, 2–4 (2000).</Citation><ArticleIdList><ArticleId IdType="pubmed">10653514</ArticleId><ArticleId IdType="doi">10.1093/toxsci/53.1.2</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson, K. J. et al. A transformative vision for an omics-based regulatory chemical testing paradigm. Toxicol. Sci. 190, 127–132 (2022). This paper proposes a logic framework to integrate tPODs into regulatory toxicity testing, outlining four principles to transform risk assessment and enhance the protection of human and ecological health.</Citation><ArticleIdList><ArticleId IdType="pubmed">36165699</ArticleId><ArticleId IdType="pmc">9702989</ArticleId><ArticleId IdType="doi">10.1093/toxsci/kfac097</ArticleId></ArticleIdList></Reference><Reference><Citation>Reardon, A. J. F. et al. From vision toward best practices: evaluating in vitro transcriptomic points of departure for application in risk assessment using a uniform workflow. Front. Toxicol. 5, 1194895 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37288009</ArticleId><ArticleId IdType="pmc">10242042</ArticleId><ArticleId IdType="doi">10.3389/ftox.2023.1194895</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas, R. S. et al. A method to integrate benchmark dose estimates with genomic data to assess the functional effects of chemical exposure. Toxicol. Sci. 98, 240–248 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17449896</ArticleId><ArticleId IdType="doi">10.1093/toxsci/kfm092</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang, L., Allen, B. C. &amp; Thomas, R. S. BMDExpress: a software tool for the benchmark dose analyses of genomic data. BMC Genomics 8, 387 (2007). This paper conceptualized and built the first software tool for BMD analysis of transcriptomic data, marking a turning point leading to quantitative analyses of toxicogenomic data.</Citation><ArticleIdList><ArticleId IdType="pubmed">17961223</ArticleId><ArticleId IdType="pmc">2198920</ArticleId><ArticleId IdType="doi">10.1186/1471-2164-8-387</ArticleId></ArticleIdList></Reference><Reference><Citation>Farmahin, R. et al. Recommended approaches in the application of toxicogenomics to derive points of departure for chemical risk assessment. Arch. Toxicol. 91, 2045–2065 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">27928627</ArticleId><ArticleId IdType="doi">10.1007/s00204-016-1886-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Pagé-Larivière, F., Crump, D. &amp; O’Brien, J. M. Transcriptomic points-of-departure from short-term exposure studies are protective of chronic effects for fish exposed to estrogenic chemicals. Toxicol. Appl. Pharmacol. 378, 114634 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31226361</ArticleId><ArticleId IdType="doi">10.1016/j.taap.2019.114634</ArticleId></ArticleIdList></Reference><Reference><Citation>US Environmental Protection Agency. Scientific Studies Supporting Development of Transcriptomic Points of Departure for EPA Transcriptomic Assessment Products (ETAPs) (2024). This report reviewed the literature and finds a high degree of concordance between tPODs from rodent studies and PODs derived from conventional toxicology, supporting the use of tPODs from 5-day, repeated dose in vivo rodent studies for use in quantitative human health assessment.</Citation></Reference><Reference><Citation>Gwinn, W. M. et al. Evaluation of 5-day in vivo rat liver and kidney with high-throughput transcriptomics for estimating benchmark doses of apical outcomes. Toxicol. Sci. 176, 343–354 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32492150</ArticleId><ArticleId IdType="pmc">7416315</ArticleId><ArticleId IdType="doi">10.1093/toxsci/kfaa081</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas, R. S. et al. Temporal concordance between apical and transcriptional points of departure for chemical risk assessment. Toxicol. Sci. 134, 180–194 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23596260</ArticleId><ArticleId IdType="doi">10.1093/toxsci/kft094</ArticleId></ArticleIdList></Reference><Reference><Citation>Ingber, D. E. Human organs-on-chips for disease modelling, drug development and personalized medicine. Nat. Rev. Genet. 23, 467–491 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35338360</ArticleId><ArticleId IdType="pmc">8951665</ArticleId><ArticleId IdType="doi">10.1038/s41576-022-00466-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakolish, C. et al. Analysis of reproducibility and robustness of a renal proximal tubule microphysiological system OrganoPlate 3-lane 40 for in vitro studies of drug transport and toxicity. Toxicol. Sci. 196, 52–70 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37555834</ArticleId><ArticleId IdType="pmc">10613961</ArticleId><ArticleId IdType="doi">10.1093/toxsci/kfad080</ArticleId></ArticleIdList></Reference><Reference><Citation>Indolfo, N. et al. Combining a microphysiological system of three organ equivalents and transcriptomics to assess toxicological endpoints for cosmetic ingredients. Lab Chip 23, 5092–5106 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37921576</ArticleId><ArticleId IdType="doi">10.1039/D3LC00546A</ArticleId></ArticleIdList></Reference><Reference><Citation>Kostrzewski, T. et al. Modelling human liver fibrosis in the context of non-alcoholic steatohepatitis using a microphysiological system. Commun. Biol. 4, 1080 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34526653</ArticleId><ArticleId IdType="pmc">8443589</ArticleId><ArticleId IdType="doi">10.1038/s42003-021-02616-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Parafati, M. et al. Human skeletal muscle tissue chip autonomous payload reveals changes in fiber type and metabolic gene expression due to spaceflight. NPJ Microgravity 9, 77 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37714852</ArticleId><ArticleId IdType="pmc">10504373</ArticleId><ArticleId IdType="doi">10.1038/s41526-023-00322-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Wetmore, B. A. et al. Integration of dosimetry, exposure, and high-throughput screening data in chemical toxicity assessment. Toxicol. Sci. 125, 157–174 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">21948869</ArticleId><ArticleId IdType="doi">10.1093/toxsci/kfr254</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Canada. Use of New Approach Methods (NAMs) in Risk Assessment https://www.canada.ca/en/health-canada/services/chemical-substances/fact-sheets/use-new-approach-methods-risk-assessment.html (2023).</Citation></Reference><Reference><Citation>Dent, M. P. et al. Paving the way for application of next generation risk assessment to safety decision-making for cosmetic ingredients. Regul. Toxicol. Pharmacol. 125, 105026 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34389358</ArticleId><ArticleId IdType="pmc">8547713</ArticleId><ArticleId IdType="doi">10.1016/j.yrtph.2021.105026</ArticleId></ArticleIdList></Reference><Reference><Citation>Organisation for Economic Co-operation and Development. Report on Considerations from Case Studies on Integrated Approaches for Testing and Assessment (IATA). https://one.oecd.org/document/env/cbc/mono(2022)36/en/pdf (OECD, 2022).</Citation></Reference><Reference><Citation>US Environmental Protection Agency. Halauxifen-methyl — New Active Ingredient Human Health Risk Assessment for Proposed Uses on Cereal Grains (Barley, Wheat, and Triticale) (EPA, 2016).</Citation></Reference><Reference><Citation>Brennan, A. et al. EPA Transcriptomic Assessment Product (ETAP) for perfluoro-3-methoxypropanoic acid. https://doi.org/10.23645/epacomptox.25352962 (2024).</Citation></Reference><Reference><Citation>Thomas, R. S. et al. Incorporating new technologies into toxicity testing and risk assessment: moving from 21st century vision to a data-driven framework. Toxicol. Sci. 136, 4–18 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23958734</ArticleId><ArticleId IdType="pmc">3829570</ArticleId><ArticleId IdType="doi">10.1093/toxsci/kft178</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagiwara, S. et al. A value of information framework for assessing the trade-offs associated with uncertainty, duration, and cost of chemical toxicity testing. Risk Anal. 43, 498–515 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">35460101</ArticleId><ArticleId IdType="doi">10.1111/risa.13931</ArticleId></ArticleIdList></Reference><Reference><Citation>Newman, A. M. et al. Determining cell type abundance and expression from bulk tissues with digital cytometry. Nat. Biotechnol. 37, 773–782 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31061481</ArticleId><ArticleId IdType="pmc">6610714</ArticleId><ArticleId IdType="doi">10.1038/s41587-019-0114-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang, F. et al. mRNA-Seq whole-transcriptome analysis of a single cell. Nat. Methods 6, 377–382 (2009).</Citation><ArticleIdList><ArticleId IdType="pubmed">19349980</ArticleId><ArticleId IdType="doi">10.1038/nmeth.1315</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao, A., Barkley, D., França, G. S. &amp; Yanai, I. Exploring tissue architecture using spatial transcriptomics. Nature 596, 211–220 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34381231</ArticleId><ArticleId IdType="pmc">8475179</ArticleId><ArticleId IdType="doi">10.1038/s41586-021-03634-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie, X. et al. Single-cell transcriptome profiling reveals neutrophil heterogeneity in homeostasis and infection. Nat. Immunol. 21, 1119–1133 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32719519</ArticleId><ArticleId IdType="pmc">7442692</ArticleId><ArticleId IdType="doi">10.1038/s41590-020-0736-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Travaglini, K. J. et al. A molecular cell atlas of the human lung from single-cell RNA sequencing. Nature 587, 619–625 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">33208946</ArticleId><ArticleId IdType="pmc">7704697</ArticleId><ArticleId IdType="doi">10.1038/s41586-020-2922-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Umbaugh, D. S., Ramachandran, A. &amp; Jaeschke, H. Spatial reconstruction of the early hepatic transcriptomic landscape after an acetaminophen overdose using single-cell RNA-sequencing. Toxicol. Sci. 182, 327–345 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33983442</ArticleId><ArticleId IdType="pmc">8331154</ArticleId><ArticleId IdType="doi">10.1093/toxsci/kfab052</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu, K. S. et al. Single-cell RNA-seq analysis reveals that prenatal arsenic exposure results in long-term, adverse effects on immune gene expression in response to influenza A infection. Toxicol. Sci. 176, 312–328 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32514536</ArticleId><ArticleId IdType="pmc">7416320</ArticleId><ArticleId IdType="doi">10.1093/toxsci/kfaa080</ArticleId></ArticleIdList></Reference><Reference><Citation>Nault, R. et al. Single-cell transcriptomics shows dose-dependent disruption of hepatic zonation by TCDD in mice. Toxicol. Sci. 191, 135–148 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36222588</ArticleId><ArticleId IdType="doi">10.1093/toxsci/kfac109</ArticleId></ArticleIdList></Reference><Reference><Citation>Han, L. et al. 89 lung single cell transcriptomics to guide the development of AOP anchored cell-based assays in response to nanoparticle exposure. Ann. Work Expo. Health 67, i59–i60 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/annweh/wxac087.144</ArticleId></ArticleIdList></Reference><Reference><Citation>No authors listed]. A call for spatial omics submissions. Nat. Genet. 56, 1 (2024).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-023-01621-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, X. et al. CellMarker: a manually curated resource of cell markers in human and mouse. Nucleic Acids Res. 47, D721–D728 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30289549</ArticleId><ArticleId IdType="doi">10.1093/nar/gky900</ArticleId></ArticleIdList></Reference><Reference><Citation>Quan, F. et al. Annotation of cell types (ACT): a convenient web server for cell type annotation. Genome Med. 15, 91 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37924118</ArticleId><ArticleId IdType="pmc">10623726</ArticleId><ArticleId IdType="doi">10.1186/s13073-023-01249-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Franzén, O., Gan, L.-M. &amp; Björkegren, J. L. M. PanglaoDB: a web server for exploration of mouse and human single-cell RNA sequencing data. Database 2019, baz046 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30951143</ArticleId><ArticleId IdType="pmc">6450036</ArticleId><ArticleId IdType="doi">10.1093/database/baz046</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim, S. H. &amp; Cho, S. Y. Single-cell transcriptomics to understand the cellular heterogeneity in toxicology. Mol. Cell. Toxicol. 19, 223–228 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13273-022-00304-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Sturla, S. J. et al. Systems toxicology: from basic research to risk assessment. Chem. Res. Toxicol. 27, 314–329 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24446777</ArticleId><ArticleId IdType="pmc">3964730</ArticleId><ArticleId IdType="doi">10.1021/tx400410s</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma, Y., Klein, H. &amp; De Jager, P. L. Considerations for integrative multi‐omic approaches to explore Alzheimer’s disease mechanisms. Brain Pathol. 30, 984–991 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32654306</ArticleId><ArticleId IdType="pmc">8018035</ArticleId><ArticleId IdType="doi">10.1111/bpa.12878</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehrmohamadi, M., Sepehri, M. H., Nazer, N. &amp; Norouzi, M. R. A comparative overview of epigenomic profiling methods. Front. Cell Dev. Biol. 9, 714687 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34368164</ArticleId><ArticleId IdType="pmc">8340004</ArticleId><ArticleId IdType="doi">10.3389/fcell.2021.714687</ArticleId></ArticleIdList></Reference><Reference><Citation>Wetmore, B. A. &amp; Merrick, B. A. Invited Review: Toxicoproteomics: proteomics applied to toxicology and pathology. Toxicol. Pathol. 32, 619–642 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">15580702</ArticleId><ArticleId IdType="doi">10.1080/01926230490518244</ArticleId></ArticleIdList></Reference><Reference><Citation>Alseekh, S. et al. Mass spectrometry-based metabolomics: a guide for annotation, quantification and best reporting practices. Nat. Methods 18, 747–756 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34239102</ArticleId><ArticleId IdType="pmc">8592384</ArticleId><ArticleId IdType="doi">10.1038/s41592-021-01197-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Züllig, T., Trötzmüller, M. &amp; Köfeler, H. C. Lipidomics from sample preparation to data analysis: a primer. Anal. Bioanal. Chem. 412, 2191–2209 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">31820027</ArticleId><ArticleId IdType="doi">10.1007/s00216-019-02241-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng, K. C., Katz, S. R., Lin, A. Y., Xin, X. &amp; Ding, Y. Whole-organism cellular pathology: a systems approach to phenomics. Adv. Genet. 95, 89–115 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27503355</ArticleId><ArticleId IdType="doi">10.1016/bs.adgen.2016.05.003</ArticleId></ArticleIdList></Reference><Reference><Citation>Bray, M.-A. et al. Cell painting, a high-content image-based assay for morphological profiling using multiplexed fluorescent dyes. Nat. Protoc. 11, 1757–1774 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27560178</ArticleId><ArticleId IdType="pmc">5223290</ArticleId><ArticleId IdType="doi">10.1038/nprot.2016.105</ArticleId></ArticleIdList></Reference><Reference><Citation>O’Connor, L. M., O’Connor, B. A., Lim, S. B., Zeng, J. &amp; Lo, C. H. Integrative multi-omics and systems bioinformatics in translational neuroscience: a data mining perspective. J. Pharm. Anal. 13, 836–850 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37719197</ArticleId><ArticleId IdType="pmc">10499660</ArticleId><ArticleId IdType="doi">10.1016/j.jpha.2023.06.011</ArticleId></ArticleIdList></Reference><Reference><Citation>Pilarczyk, M. et al. Connecting omics signatures and revealing biological mechanisms with iLINCS. Nat. Commun. 13, 4678 (2022). iLINCS is a web platform that enables integrative analysis of extensive omics data and pre-computed signatures for applications such as analysis of perturbagen signatures, signature-driven drug repositioning and mode of action analysis using a low-code environment.</Citation><ArticleIdList><ArticleId IdType="pubmed">35945222</ArticleId><ArticleId IdType="pmc">9362980</ArticleId><ArticleId IdType="doi">10.1038/s41467-022-32205-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, C., Lye, X., Kaalia, R., Kumar, P. &amp; Rajapakse, J. C. Deep learning and multi-omics approach to predict drug responses in cancer. BMC Bioinformatics 22, 632 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">36443676</ArticleId><ArticleId IdType="pmc">9703655</ArticleId><ArticleId IdType="doi">10.1186/s12859-022-04964-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Norris, J. L. et al. Integrated, high-throughput, multiomics platform enables data-driven construction of cellular responses and reveals global drug mechanisms of action. J. Proteome Res. 16, 1364–1375 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28088864</ArticleId><ArticleId IdType="doi">10.1021/acs.jproteome.6b01004</ArticleId></ArticleIdList></Reference><Reference><Citation>Way, G. P. et al. Morphology and gene expression profiling provide complementary information for mapping cell state. Cell Syst. 13, 911–923.e9 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">36395727</ArticleId><ArticleId IdType="pmc">10246468</ArticleId><ArticleId IdType="doi">10.1016/j.cels.2022.10.001</ArticleId></ArticleIdList></Reference><Reference><Citation>Haghighi, M., Caicedo, J., Cimini, B. A. &amp; Carpenter, A. E. High-dimensional gene expression and morphology profiles of cells across 28,000 genetic and chemical perturbations. Nat. Methods 19, 1550–1557 (2022). Used data fusion analysis techniques to combine structural information, gene expression profiles and imaging-based phenotypic profiles to predict mitochondrial toxicity; greater sensitivity and accuracy in predictions were achieved when combining disparate omics data types.</Citation><ArticleIdList><ArticleId IdType="pubmed">36344834</ArticleId><ArticleId IdType="pmc">10012424</ArticleId><ArticleId IdType="doi">10.1038/s41592-022-01667-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Seal, S. et al. Integrating cell morphology with gene expression and chemical structure to aid mitochondrial toxicity detection. Commun. Biol. 5, 858 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35999457</ArticleId><ArticleId IdType="pmc">9399120</ArticleId><ArticleId IdType="doi">10.1038/s42003-022-03763-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Alfano, R. et al. A multi-omic analysis of birthweight in newborn cord blood reveals new underlying mechanisms related to cholesterol metabolism. Metabolism 110, 154292 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32553738</ArticleId><ArticleId IdType="pmc">7450273</ArticleId><ArticleId IdType="doi">10.1016/j.metabol.2020.154292</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolters, J. E. J. et al. Integrated ‘omics analysis reveals new drug-induced mitochondrial perturbations in human hepatocytes. Toxicol. Lett. 289, 1–13 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29501571</ArticleId><ArticleId IdType="doi">10.1016/j.toxlet.2018.02.026</ArticleId></ArticleIdList></Reference><Reference><Citation>Housman, D. &amp; Ledley, F. D. Why pharmacogenomics? Why now? Nat. Biotechnol. 16, 2–3 (1998).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/5134</ArticleId></ArticleIdList></Reference><Reference><Citation>Pirmohamed, M. Pharmacogenomics: current status and future perspectives. Nat. Rev. Genet. 24, 350–362 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36707729</ArticleId><ArticleId IdType="doi">10.1038/s41576-022-00572-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh, A. V. et al. Integrative toxicogenomics: advancing precision medicine and toxicology through artificial intelligence and OMICs technology. Biomed. Pharmacother. 163, 114784 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37121152</ArticleId><ArticleId IdType="doi">10.1016/j.biopha.2023.114784</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung, M. K. et al. Decoding the exposome: data science methodologies and implications in exposome-wide association studies (ExWASs). Exposome 4, osae001 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">38344436</ArticleId><ArticleId IdType="pmc">10857773</ArticleId><ArticleId IdType="doi">10.1093/exposome/osae001</ArticleId></ArticleIdList></Reference><Reference><Citation>Chappell, G. A. &amp; Rager, J. E. Epigenetics in chemical-induced genotoxic carcinogenesis. Curr. Opin. Toxicol. 6, 10–17 (2017).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cotox.2017.06.007</ArticleId></ArticleIdList></Reference><Reference><Citation>Louro, H. &amp; Silva, M. J. Nanotoxicology in Safety Assessment of Nanomaterials Vol. 1357 (Springer International Publishing, 2022).</Citation></Reference><Reference><Citation>Saarimäki, L. A. et al. Toxicogenomics analysis of dynamic dose-response in macrophages highlights molecular alterations relevant for multi-walled carbon nanotube-induced lung fibrosis. NanoImpact 20, 100274 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.impact.2020.100274</ArticleId></ArticleIdList></Reference><Reference><Citation>Bannuscher, A. et al. A multi-omics approach reveals mechanisms of nanomaterial toxicity and structure–activity relationships in alveolar macrophages. Nanotoxicology 14, 181–195 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">31774342</ArticleId><ArticleId IdType="doi">10.1080/17435390.2019.1684592</ArticleId></ArticleIdList></Reference><Reference><Citation>Canzler, S. et al. Prospects and challenges of multi-omics data integration in toxicology. Arch. Toxicol. 94, 371–388 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32034435</ArticleId><ArticleId IdType="doi">10.1007/s00204-020-02656-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim, S., Hollinger, H. &amp; Radke, E. G. ‘Omics in environmental epidemiological studies of chemical exposures: a systematic evidence map. Environ. Int. 164, 107243 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35551006</ArticleId><ArticleId IdType="doi">10.1016/j.envint.2022.107243</ArticleId></ArticleIdList></Reference><Reference><Citation>Rager, J. E. et al. Benchmark dose modeling estimates of the concentrations of inorganic arsenic that induce changes to the neonatal transcriptome, proteome, and epigenome in a pregnancy cohort. Chem. Res. Toxicol. 30, 1911–1920 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28927277</ArticleId><ArticleId IdType="doi">10.1021/acs.chemrestox.7b00221</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohammadi-Shemirani, P., Sood, T. &amp; Paré, G. From ‘omics to multi-omics technologies: the discovery of novel causal mediators. Curr. Atheroscler. Rep. 25, 55–65 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36595202</ArticleId><ArticleId IdType="pmc">9807989</ArticleId><ArticleId IdType="doi">10.1007/s11883-022-01078-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Kayalar, O., Rajabi, H., Mortazavi, D. &amp; Bayram, H. In Oncology: Genomics, Precision Medicine and Therapeutic Targets (eds Tuli, H. S. &amp; Yerer Aycan, M. B.) 237–263 (Springer Nature, 2023).</Citation></Reference><Reference><Citation>Verheijen, M. et al. Multi-omics HeCaToS dataset of repeated dose toxicity for cardiotoxic &amp; hepatotoxic compounds. Sci. Data 9, 699 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">36376331</ArticleId><ArticleId IdType="pmc">9663581</ArticleId><ArticleId IdType="doi">10.1038/s41597-022-01825-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Nyffeler, J. et al. Combining phenotypic profiling and targeted RNA-Seq reveals linkages between transcriptional perturbations and chemical effects on cell morphology: retinoic acid as an example. Toxicol. Appl. Pharmacol. 444, 116032 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35483669</ArticleId><ArticleId IdType="pmc">10894461</ArticleId><ArticleId IdType="doi">10.1016/j.taap.2022.116032</ArticleId></ArticleIdList></Reference><Reference><Citation>Payton, A. et al. Navigating the bridge between wet and dry lab toxicology research to address current challenges with high-dimensional data. Front. Toxicol. 5, 1171175 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37304253</ArticleId><ArticleId IdType="pmc">10250703</ArticleId><ArticleId IdType="doi">10.3389/ftox.2023.1171175</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogris, C., Hu, Y., Arloth, J. &amp; Müller, N. S. Versatile knowledge guided network inference method for prioritizing key regulatory factors in multi-omics data. Sci. Rep. 11, 6806 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33762588</ArticleId><ArticleId IdType="pmc">7990936</ArticleId><ArticleId IdType="doi">10.1038/s41598-021-85544-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Uppal, K., Ma, C., Go, Y.-M. &amp; Jones, D. P. xMWAS: a data-driven integration and differential network analysis tool. Bioinformatics 34, 701–702 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29069296</ArticleId><ArticleId IdType="doi">10.1093/bioinformatics/btx656</ArticleId></ArticleIdList></Reference><Reference><Citation>Tripodi, I. J. et al. Applying knowledge-driven mechanistic inference to toxicogenomics. Toxicol. Vitr. 66, 104877 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tiv.2020.104877</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis, A. P. et al. Comparative toxicogenomics database: a knowledgebase and discovery tool for chemical–gene–disease networks. Nucleic Acids Res. 37, D786–D792 (2009).</Citation><ArticleIdList><ArticleId IdType="pubmed">18782832</ArticleId><ArticleId IdType="doi">10.1093/nar/gkn580</ArticleId></ArticleIdList></Reference><Reference><Citation>Stuart, T. et al. Comprehensive integration of single-cell data. Cell 177, 1888–1902.e21 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31178118</ArticleId><ArticleId IdType="pmc">6687398</ArticleId><ArticleId IdType="doi">10.1016/j.cell.2019.05.031</ArticleId></ArticleIdList></Reference><Reference><Citation>Melis, J. P. M. et al. In vivo murine hepatic microRNA and mRNA expression signatures predicting the (non-)genotoxic carcinogenic potential of chemicals. Arch. Toxicol. 88, 1023–1034 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24390151</ArticleId><ArticleId IdType="doi">10.1007/s00204-013-1189-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi, L. et al. The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models. Nat. Biotechnol. 28, 827–838 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20676074</ArticleId><ArticleId IdType="doi">10.1038/nbt.1665</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng, S., Masarone, S., Watson, D. &amp; Barnes, M. R. The benefits and pitfalls of machine learning for biomarker discovery. Cell Tissue Res. 394, 17–31 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37498390</ArticleId><ArticleId IdType="pmc">10558383</ArticleId><ArticleId IdType="doi">10.1007/s00441-023-03816-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Svoboda, D. L., Saddler, T. &amp; Auerbach, S. S. In Advances in Computational Toxicology: Methodologies and Applications in Regulatory Science (ed. Hong, H.) 141–157 (Springer International Publishing, 2019).</Citation></Reference><Reference><Citation>Smith, B. P. et al. Identification of early liver toxicity gene biomarkers using comparative supervised machine learning. Sci. Rep. 10, 19128 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">33154507</ArticleId><ArticleId IdType="pmc">7645727</ArticleId><ArticleId IdType="doi">10.1038/s41598-020-76129-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang, J. et al. Unraveling the mechanisms underlying drug-induced cholestatic liver injury: identifying key genes using machine learning techniques on human in vitro data sets. Arch. Toxicol. 97, 2969–2981 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37603094</ArticleId><ArticleId IdType="pmc">10504391</ArticleId><ArticleId IdType="doi">10.1007/s00204-023-03583-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Moein, M. et al. Chemistry-based modeling on phenotype-based drug-induced liver injury annotation: from public to proprietary data. Chem. Res. Toxicol. 36, 1238–1247 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37556769</ArticleId><ArticleId IdType="pmc">10445287</ArticleId><ArticleId IdType="doi">10.1021/acs.chemrestox.2c00378</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, X., Roberts, R., Liu, Z. &amp; Tong, W. A generative adversarial network model alternative to animal studies for clinical pathology assessment. Nat. Commun. 14, 7141 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37932302</ArticleId><ArticleId IdType="pmc">10628291</ArticleId><ArticleId IdType="doi">10.1038/s41467-023-42933-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, X., Roberts, R., Tong, W. &amp; Liu, Z. Tox-GAN: an artificial intelligence approach alternative to animal studies — a case study with toxicogenomics. Toxicol. Sci. 186, 242–259 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">34971401</ArticleId><ArticleId IdType="doi">10.1093/toxsci/kfab157</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, T., Roberts, R., Liu, Z. &amp; Tong, W. TransOrGAN: an artificial intelligence mapping of rat transcriptomic profiles between organs, ages, and sexes. Chem. Res. Toxicol. 36, 916–925 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37200521</ArticleId><ArticleId IdType="pmc">10433534</ArticleId><ArticleId IdType="doi">10.1021/acs.chemrestox.3c00037</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkinson, M. D. et al. The FAIR guiding principles for scientific data management and stewardship. Sci. Data 3, 160018 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">26978244</ArticleId><ArticleId IdType="pmc">4792175</ArticleId><ArticleId IdType="doi">10.1038/sdata.2016.18</ArticleId></ArticleIdList></Reference><Reference><Citation>Brazma, A. et al. ArrayExpress — a public repository for microarray gene expression data at the EBI. Nucleic Acids Res. 31, 68–71 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">12519949</ArticleId><ArticleId IdType="pmc">165538</ArticleId><ArticleId IdType="doi">10.1093/nar/gkg091</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolesnikov, N. et al. ArrayExpress update — simplifying data submissions. Nucleic Acids Res. 43, D1113–D1116 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25361974</ArticleId><ArticleId IdType="doi">10.1093/nar/gku1057</ArticleId></ArticleIdList></Reference><Reference><Citation>Clough, E. &amp; Barrett, T. In Statistical Genomics: Methods and Protocols (eds Mathé, E. &amp; Davis, S.) 93–110 (Springer, 2016).</Citation></Reference><Reference><Citation>Waters, M. et al. Systems toxicology and the Chemical Effects in Biological Systems (CEBS) knowledge base. EHP Toxicogenomics 111, 15–28 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">12735106</ArticleId></ArticleIdList></Reference><Reference><Citation>Fostel, J. et al. Chemical effects in biological systems–data dictionary (CEBS-DD): a compendium of terms for the capture and integration of biological study design description, conventional phenotypes, and ’omics data. Toxicol. Sci. 88, 585–601 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">16150882</ArticleId><ArticleId IdType="doi">10.1093/toxsci/kfi315</ArticleId></ArticleIdList></Reference><Reference><Citation>Lea, I. A., Gong, H., Paleja, A., Rashid, A. &amp; Fostel, J. CEBS: a comprehensive annotated database of toxicological data. Nucleic Acids Res. 45, D964–D971 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">27899660</ArticleId><ArticleId IdType="doi">10.1093/nar/gkw1077</ArticleId></ArticleIdList></Reference><Reference><Citation>Martini, C. et al. CEBS update: curated toxicology database with enhanced tools for data integration. Nucleic Acids Res. 50, D1156–D1163 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">34751388</ArticleId><ArticleId IdType="doi">10.1093/nar/gkab981</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattingly, C. J., Colby, G. T., Forrest, J. N. &amp; Boyer, J. L. The comparative toxicogenomics database (CTD). Environ. Health Perspect. 111, 793–795 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">12760826</ArticleId><ArticleId IdType="pmc">1241500</ArticleId><ArticleId IdType="doi">10.1289/ehp.6028</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis, A. P. et al. Comparative toxicogenomics database (CTD): update 2023. Nucleic Acids Res. 51, D1257–D1262 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36169237</ArticleId><ArticleId IdType="doi">10.1093/nar/gkac833</ArticleId></ArticleIdList></Reference><Reference><Citation>Keenan, A. B. et al. The library of integrated network-based cellular signatures NIH program: system-level cataloging of human cells response to perturbations. Cell Syst. 6, 13–24 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29199020</ArticleId><ArticleId IdType="doi">10.1016/j.cels.2017.11.001</ArticleId></ArticleIdList></Reference><Reference><Citation>Stathias, V. et al. LINCS Data Portal 2.0: next generation access point for perturbation-response signatures. Nucleic Acids Res. 48, D431–D439 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">31701147</ArticleId><ArticleId IdType="doi">10.1093/nar/gkz1023</ArticleId></ArticleIdList></Reference><Reference><Citation>Evangelista, J. E. et al. SigCom LINCS: data and metadata search engine for a million gene expression signatures. Nucleic Acids Res. 50, W697–W709 (2022). LINCS is a powerful resource to enhance understanding of drivers of human diseases by providing data that systematically catalogues diverse cellular responses to perturbations, including drugs and mutations, using advanced methods such as transcript profiling and mass spectrometry.</Citation><ArticleIdList><ArticleId IdType="pubmed">35524556</ArticleId><ArticleId IdType="pmc">9252724</ArticleId><ArticleId IdType="doi">10.1093/nar/gkac328</ArticleId></ArticleIdList></Reference><Reference><Citation>Hendrickx, D. M. et al. diXa: a data infrastructure for chemical safety assessment. Bioinformatics 31, 1505–1507 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25505093</ArticleId><ArticleId IdType="doi">10.1093/bioinformatics/btu827</ArticleId></ArticleIdList></Reference><Reference><Citation>Nair, S. K. et al. ToxicoDB: an integrated database to mine and visualize large-scale toxicogenomic datasets. Nucleic Acids Res. 48, W455–W462 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32421831</ArticleId><ArticleId IdType="pmc">7319553</ArticleId><ArticleId IdType="doi">10.1093/nar/gkaa390</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Zalm, A. J. et al. A framework for establishing scientific confidence in new approach methodologies. Arch. Toxicol. 96, 2865–2879 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35987941</ArticleId><ArticleId IdType="pmc">9525335</ArticleId><ArticleId IdType="doi">10.1007/s00204-022-03365-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Stucki, A. O. et al. Use of new approach methodologies (NAMs) to meet regulatory requirements for the assessment of industrial chemicals and pesticides for effects on human health. Front. Toxicol. 4, 964553 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">36119357</ArticleId><ArticleId IdType="pmc">9475191</ArticleId><ArticleId IdType="doi">10.3389/ftox.2022.964553</ArticleId></ArticleIdList></Reference><Reference><Citation>Vinken, M. et al. Adverse outcome pathways: a concise introduction for toxicologists. Arch. Toxicol. 91, 3697–3707 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28660287</ArticleId><ArticleId IdType="pmc">5805086</ArticleId><ArticleId IdType="doi">10.1007/s00204-017-2020-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Ankley, G. T. et al. Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment. Environ. Toxicol. Chem. 29, 730–741 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20821501</ArticleId><ArticleId IdType="doi">10.1002/etc.34</ArticleId></ArticleIdList></Reference><Reference><Citation>Organisation for Economic Co-operation and Development. Users’ Handbook Supplement to the Guidance Document for Developing and Assessing Adverse Outcome Pathways https://www.oecd-ilibrary.org/environment/users-handbook-supplement-to-the-guidance-document-for-developing-and-assessing-adverse-outcome-pathways_5jlv1m9d1g32-en (OECD, 2018).</Citation></Reference><Reference><Citation>Gou, X. et al. Prediction of zebrafish embryonic developmental toxicity by integrating omics with adverse outcome pathway. J. Hazard. Mater. 448, 130958 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36860045</ArticleId><ArticleId IdType="doi">10.1016/j.jhazmat.2023.130958</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia, P., Wang, P., Fang, W. &amp; Zhang, X. In Advances in Toxicology and Risk Assessment of Nanomaterials and Emerging Contaminants (eds Guo, L.-H. &amp; Mortimer, M.) 307–324 (Springer, 2022).</Citation></Reference><Reference><Citation>Jagiello, K. et al. Transcriptomics-based and AOP-informed structure–activity relationships to predict pulmonary pathology induced by multiwalled carbon nanotubes. Small 17, 2003465 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/smll.202003465</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin, Y. et al. High throughput data-based, toxicity pathway-oriented development of a quantitative adverse outcome pathway network linking AHR activation to lung damages. J. Hazard. Mater. 425, 128041 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">34906874</ArticleId><ArticleId IdType="doi">10.1016/j.jhazmat.2021.128041</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakker, R. et al. Combining time-resolved transcriptomics and proteomics data for Adverse Outcome Pathway refinement in ecotoxicology. Sci. Total Environ. 869, 161740 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36708843</ArticleId><ArticleId IdType="doi">10.1016/j.scitotenv.2023.161740</ArticleId></ArticleIdList></Reference><Reference><Citation>Vinken, M. Omics-based input and output in the development and use of adverse outcome pathways. Curr. Opin. Toxicol. 18, 8–12 (2019).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cotox.2019.02.006</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziemann, M., Poulain, P. &amp; Bora, A. The five pillars of computational reproducibility: bioinformatics and beyond. Brief. Bioinform. 24, bbad375 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37870287</ArticleId><ArticleId IdType="pmc">10591307</ArticleId><ArticleId IdType="doi">10.1093/bib/bbad375</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrill, J. et al. Considerations for strategic use of high-throughput transcriptomics chemical screening data in regulatory decisions. Curr. Opin. Toxicol. 15, 64–75 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31501805</ArticleId><ArticleId IdType="pmc">6733036</ArticleId><ArticleId IdType="doi">10.1016/j.cotox.2019.05.004</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrill, J. A. et al. Exploring the effects of experimental parameters and data modeling approaches on in vitro transcriptomic point-of-departure estimates. Toxicology 501, 153694 (2024). Computational methods for calculating tPODs produced from high-throughput transcriptomic data are explored, underscoring the sensitivity of tPOD calculations to both computational approaches and experimental conditions, and emphasizing the need for diverse cell types and methodologies in chemical hazard screening.</Citation><ArticleIdList><ArticleId IdType="pubmed">38043774</ArticleId><ArticleId IdType="doi">10.1016/j.tox.2023.153694</ArticleId></ArticleIdList></Reference><Reference><Citation>SEQC/MAQC-III Consortium. A comprehensive assessment of RNA-seq accuracy, reproducibility and information content by the Sequencing Quality Control Consortium. Nat. Biotechnol. 32, 903–914 (2014).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.2957</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul Friedman, K. et al. Reproducibility of organ-level effects in repeat dose animal studies. Comput. Toxicol. 28, 1–17 (2023). This paper finds variable concordance rates for chemical effects across organs and methods, substantial unexplained variance in treatment effects, and discrepancies in organ-level effects between chronic and subchronic dosing regimens for animal studies used in conventional toxicology, providing a benchmark for the performance of new methodologies.</Citation></Reference><Reference><Citation>US Environmental Protection Agency. Value of Information Case Study on the Human Health and Economic Trade-offs Associated with the Timeliness, Uncertainty, and Costs of the Draft EPA Transcriptomic Assessment Product (ETAP) (EPA, 2024).</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>